Ouabain contributes to kidney damage in a rat model of renal ischemia-reperfusion injury

Luca Villa, Roberta Buono, Mara Ferrandi, Isabella Molinari, Fabio Benigni, Arianna Bettiga, Giorgia Colciago, Masami Ikehata, Elisabetta Messaggio, Maria Pia Rastaldi, Francesco Montorsi, Andrea Salonia, Paolo Manunta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Warm renal ischemia performed during partial nephrectomy has been found to be associated with kidney disease. Since endogenous ouabain (EO) is a neuro-endocrine hormone involved in renal damage, we evaluated the role of EO in renal ischemia-reperfusion injury (IRI). We measured plasma and renal EO variations and markers of glomerular and tubular damage (nephrin, KIM-1, Kidney-Injury-Molecule-1, α1 Na-K ATPase) and the protective effect of the ouabain inhibitor, rostafuroxin. We studied five groups of rats: (1) normal; (2) infused for eight weeks with ouabain (30 μg/kg/day, OHR) or (3) saline; (4) ouabain; or (5) saline-infused rats orally treated with 100 μg/kg/day rostafuroxin for four weeks. In group 1, 2–3 h after IRI, EO increased in ischemic kidneys while decreased in plasma. Nephrin progressively decreased and KIM-1 mRNA increased starting from 24 h. Ouabain infusion (group 2) increased blood pressure (from 111.7 to 153.4 mmHg) and ouabain levels in plasma and kidneys. In OHR ischemic kidneys at 120 h from IRI, nephrin, and KIM-1 changes were greater than those detected in the controls infused with saline (group 3). All these changes were blunted by rostafuroxin treatment (groups 4 and 5). These findings support the role of EO in IRI and suggest that rostafuroxin pre-treatment of patients before partial nephrectomy with warm ischemia may reduce IRI, particularly in those with high EO.

Original languageEnglish
Article number1728
JournalInternational Journal of Molecular Sciences
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 14 2016

Fingerprint

ischemia
kidneys
Ouabain
Reperfusion Injury
rats
Rats
damage
Kidney
Plasmas
Hormones
Blood pressure
Warm Ischemia
kidney diseases
Molecules
Nephrectomy
blood pressure
hormones
pretreatment
markers
inhibitors

Keywords

  • Na-K ATPase
  • Nephrin
  • Ouabain
  • Renal damage
  • Rostafuroxin
  • Warm ischemia

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Ouabain contributes to kidney damage in a rat model of renal ischemia-reperfusion injury. / Villa, Luca; Buono, Roberta; Ferrandi, Mara; Molinari, Isabella; Benigni, Fabio; Bettiga, Arianna; Colciago, Giorgia; Ikehata, Masami; Messaggio, Elisabetta; Rastaldi, Maria Pia; Montorsi, Francesco; Salonia, Andrea; Manunta, Paolo.

In: International Journal of Molecular Sciences, Vol. 17, No. 10, 1728, 14.10.2016.

Research output: Contribution to journalArticle

Villa, Luca ; Buono, Roberta ; Ferrandi, Mara ; Molinari, Isabella ; Benigni, Fabio ; Bettiga, Arianna ; Colciago, Giorgia ; Ikehata, Masami ; Messaggio, Elisabetta ; Rastaldi, Maria Pia ; Montorsi, Francesco ; Salonia, Andrea ; Manunta, Paolo. / Ouabain contributes to kidney damage in a rat model of renal ischemia-reperfusion injury. In: International Journal of Molecular Sciences. 2016 ; Vol. 17, No. 10.
@article{464a4556ba284cbe8d76263c26d5d37e,
title = "Ouabain contributes to kidney damage in a rat model of renal ischemia-reperfusion injury",
abstract = "Warm renal ischemia performed during partial nephrectomy has been found to be associated with kidney disease. Since endogenous ouabain (EO) is a neuro-endocrine hormone involved in renal damage, we evaluated the role of EO in renal ischemia-reperfusion injury (IRI). We measured plasma and renal EO variations and markers of glomerular and tubular damage (nephrin, KIM-1, Kidney-Injury-Molecule-1, α1 Na-K ATPase) and the protective effect of the ouabain inhibitor, rostafuroxin. We studied five groups of rats: (1) normal; (2) infused for eight weeks with ouabain (30 μg/kg/day, OHR) or (3) saline; (4) ouabain; or (5) saline-infused rats orally treated with 100 μg/kg/day rostafuroxin for four weeks. In group 1, 2–3 h after IRI, EO increased in ischemic kidneys while decreased in plasma. Nephrin progressively decreased and KIM-1 mRNA increased starting from 24 h. Ouabain infusion (group 2) increased blood pressure (from 111.7 to 153.4 mmHg) and ouabain levels in plasma and kidneys. In OHR ischemic kidneys at 120 h from IRI, nephrin, and KIM-1 changes were greater than those detected in the controls infused with saline (group 3). All these changes were blunted by rostafuroxin treatment (groups 4 and 5). These findings support the role of EO in IRI and suggest that rostafuroxin pre-treatment of patients before partial nephrectomy with warm ischemia may reduce IRI, particularly in those with high EO.",
keywords = "Na-K ATPase, Nephrin, Ouabain, Renal damage, Rostafuroxin, Warm ischemia",
author = "Luca Villa and Roberta Buono and Mara Ferrandi and Isabella Molinari and Fabio Benigni and Arianna Bettiga and Giorgia Colciago and Masami Ikehata and Elisabetta Messaggio and Rastaldi, {Maria Pia} and Francesco Montorsi and Andrea Salonia and Paolo Manunta",
year = "2016",
month = "10",
day = "14",
doi = "10.3390/ijms17101728",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "10",

}

TY - JOUR

T1 - Ouabain contributes to kidney damage in a rat model of renal ischemia-reperfusion injury

AU - Villa, Luca

AU - Buono, Roberta

AU - Ferrandi, Mara

AU - Molinari, Isabella

AU - Benigni, Fabio

AU - Bettiga, Arianna

AU - Colciago, Giorgia

AU - Ikehata, Masami

AU - Messaggio, Elisabetta

AU - Rastaldi, Maria Pia

AU - Montorsi, Francesco

AU - Salonia, Andrea

AU - Manunta, Paolo

PY - 2016/10/14

Y1 - 2016/10/14

N2 - Warm renal ischemia performed during partial nephrectomy has been found to be associated with kidney disease. Since endogenous ouabain (EO) is a neuro-endocrine hormone involved in renal damage, we evaluated the role of EO in renal ischemia-reperfusion injury (IRI). We measured plasma and renal EO variations and markers of glomerular and tubular damage (nephrin, KIM-1, Kidney-Injury-Molecule-1, α1 Na-K ATPase) and the protective effect of the ouabain inhibitor, rostafuroxin. We studied five groups of rats: (1) normal; (2) infused for eight weeks with ouabain (30 μg/kg/day, OHR) or (3) saline; (4) ouabain; or (5) saline-infused rats orally treated with 100 μg/kg/day rostafuroxin for four weeks. In group 1, 2–3 h after IRI, EO increased in ischemic kidneys while decreased in plasma. Nephrin progressively decreased and KIM-1 mRNA increased starting from 24 h. Ouabain infusion (group 2) increased blood pressure (from 111.7 to 153.4 mmHg) and ouabain levels in plasma and kidneys. In OHR ischemic kidneys at 120 h from IRI, nephrin, and KIM-1 changes were greater than those detected in the controls infused with saline (group 3). All these changes were blunted by rostafuroxin treatment (groups 4 and 5). These findings support the role of EO in IRI and suggest that rostafuroxin pre-treatment of patients before partial nephrectomy with warm ischemia may reduce IRI, particularly in those with high EO.

AB - Warm renal ischemia performed during partial nephrectomy has been found to be associated with kidney disease. Since endogenous ouabain (EO) is a neuro-endocrine hormone involved in renal damage, we evaluated the role of EO in renal ischemia-reperfusion injury (IRI). We measured plasma and renal EO variations and markers of glomerular and tubular damage (nephrin, KIM-1, Kidney-Injury-Molecule-1, α1 Na-K ATPase) and the protective effect of the ouabain inhibitor, rostafuroxin. We studied five groups of rats: (1) normal; (2) infused for eight weeks with ouabain (30 μg/kg/day, OHR) or (3) saline; (4) ouabain; or (5) saline-infused rats orally treated with 100 μg/kg/day rostafuroxin for four weeks. In group 1, 2–3 h after IRI, EO increased in ischemic kidneys while decreased in plasma. Nephrin progressively decreased and KIM-1 mRNA increased starting from 24 h. Ouabain infusion (group 2) increased blood pressure (from 111.7 to 153.4 mmHg) and ouabain levels in plasma and kidneys. In OHR ischemic kidneys at 120 h from IRI, nephrin, and KIM-1 changes were greater than those detected in the controls infused with saline (group 3). All these changes were blunted by rostafuroxin treatment (groups 4 and 5). These findings support the role of EO in IRI and suggest that rostafuroxin pre-treatment of patients before partial nephrectomy with warm ischemia may reduce IRI, particularly in those with high EO.

KW - Na-K ATPase

KW - Nephrin

KW - Ouabain

KW - Renal damage

KW - Rostafuroxin

KW - Warm ischemia

UR - http://www.scopus.com/inward/record.url?scp=84991571438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991571438&partnerID=8YFLogxK

U2 - 10.3390/ijms17101728

DO - 10.3390/ijms17101728

M3 - Article

AN - SCOPUS:84991571438

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

M1 - 1728

ER -